A multi-regional, randomized evaluation of the lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in patients with hypercholesterolemia or low HDL-C -Density Lipoprotein Cholesterol.
2016 ESC Cogress, 27 - 31 August 2016, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Kocaeli University Affiliated: Yes